These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35904131)

  • 1. YTGT: A new high-prevalence antigen in the Yt blood group system in two unrelated Native Americans and transfusion management.
    Van Buren NL; Gillen B; Lomas-Francis C; Burgos A; Pease D; Beaver M; Imbryk A; Dugger J; Fugate A; Hebel E; Lodermeier M; Vege S; Westhoff CM
    Transfusion; 2022 Sep; 62(9):1917-1922. PubMed ID: 35904131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemolytic transfusion reaction caused by anti-Yt
    Raos M; Thornton N; Lukic M; Golubic Cepulic B
    Immunohematology; 2021 Mar; 37(1):13-17. PubMed ID: 33962487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the Cartwright (Yt) blood group system.
    George MR
    Immunohematology; 2019 Dec; 35(4):154-155. PubMed ID: 31935332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INRA, a new high-frequency antigen in the INDIAN (IN023) blood group system.
    Joshi SR; Sheladiya A; Mendapara-Dobariya KV
    Asian J Transfus Sci; 2017; 11(2):121-123. PubMed ID: 28970678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel single-nucleotide change in GYP*A in a person who made an alloantibody to a new high-prevalence MNS antigen called ENEV.
    Velliquette RW; Hu Z; Lomas-Francis C; Hue-Roye K; Allen JL; Mirabella D; Reid ME
    Transfusion; 2010 Apr; 50(4):856-60. PubMed ID: 20003059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New method for overcoming the interference produced by anti-CD38 monoclonal antibodies in compatibility testing.
    Izaguirre EC; Del Mar Luis-Hidalgo M; González LL; Castaño CA
    Blood Transfus; 2020 Jul; 18(4):290-294. PubMed ID: 32530397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new high-prevalence LW antigen detected by an antibody in an Indigenous Australian homozygous for LW*A c.309C>A variant.
    Lopez GH; Wilson B; Millard GM; Cawthorne TL; Grey DE; Fong EA; Flower RL; Hyland CA; Liew YW
    Vox Sang; 2022 Jul; 117(7):958-965. PubMed ID: 35412682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On a much higher than reported incidence of anti-c in R1R1 patients with anti-E.
    Judd WJ; Dake LR; Davenport RD
    Immunohematology; 2005; 21(3):94-6. PubMed ID: 16178665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2.
    Lemay AS; Tong TN; Branch DR; Huang M; Sumner C; Oldfield L; Hawes J; Cserti-Gazdewich CM; Lau W
    Transfusion; 2018 Nov; 58(11):2506-2512. PubMed ID: 30299537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of anti-Yta antibody in a Yt(a+) patient.
    Mazzi G; Raineri A; Santarossa L; De Roia D; Orazi BM
    Vox Sang; 1994; 66(2):130-2. PubMed ID: 8184594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of anti-Yt(b). Report of a case using a 51chromium red cell survival study.
    Levy GJ; Selset G; McQuiston D; Nance SJ; Garratty G; Smith LE; Goldfinger D
    Transfusion; 1988; 28(3):265-7. PubMed ID: 3285526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-i causing acute hemolysis following a negative immediate-spin crossmatch.
    Judd WJ; Steiner EA; Abruzzo LV; Davenport RD; Oberman HA; Pehta JC; Nance SJ
    Transfusion; 1992; 32(6):572-5. PubMed ID: 1502712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
    Shirey RS; Boyd JS; Parwani AV; Tanz WS; Ness PM; King KE
    Transfusion; 2002 Nov; 42(11):1435-41. PubMed ID: 12421216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adsorption of autoantibodies in the presence of LISS to detect alloantibodies underlying warm autoantibodies.
    Chiaroni J; Touinssi M; Mazet M; De Micco P; Ferrera V
    Transfusion; 2003 May; 43(5):651-5. PubMed ID: 12702189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First example of hemolytic disease of the newborn caused by anti-Or and confirmation of the molecular basis of Or.
    Reid ME; Sausais L; Oyen R; Storry JR; Shukla H; Hsu T; Lim SM
    Vox Sang; 2000; 79(3):180-2. PubMed ID: 11111238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
    Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a-b-) phenotype.
    Rao N; Whitsett CF; Oxendine SM; Telen MJ
    Blood; 1993 Feb; 81(3):815-9. PubMed ID: 8427972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.